Ready to make some serious money? Wall Street Warrior Timothy Sykes isn't playing around -- he wants to make you rich. In this edition of StockWatch: Between the Bells, the MSN Money host and author of An American Hedge Fund: How I Made $2 Million as a Stock Operator & Created a Hedge Fund riffs -- and dances -- on a fistful of market strategies.

Tim has three daring tips for you. Digital content storage provider Isilon Systems (NASDAQ: ISLN) is sitting at an all-time low, more than 70% off its high at the start of the year, and looks priced to buy. Genetics biotech Illumina Inc. (NASDAQ: ILMN) is currently trading around $52; Tim sees ILMN climbing to $60. Sound a little too risky? Tim suggests checking out The Bruce Fund (BRUFX), a mutual fund focusing on domestic common stock, convertible bonds and zero-coupon government bonds.

Considering a short-selling strategy? Tim calls out China Precision Steel (NASDAQ: CPSL), which has jumped more than three-fold in little more than a week and looks set to slide.

Jamba Juice (NASDAQ: JMBA), meanwhile, is giving Tim fits -- revenues are up while same-store sales are slipping. He advises to stay away from JMBA.

Enjoy the clip, and let us know which of your favorite stock gurus you'd like to hear from in the next StockWatch: Between the Bells!

MOST NOTEWORTHY: The systems technology sector, Auxilium Pharmaceuticals (AUXL) and BioSante Pharm (BPA) were today's noteworthy initiations:

• In the systems technology sector, JP Morgan initiated coverage on CommVault Systems (NASDAQ: CVLT) and Double-Take Software, Inc (NASDAQ: DBTK) with Overweight ratings, Isilon Systems (NASDAQ: ISLN) and Opsware Inc (NASDAQ: OPSW) with Neutral ratings and Avocent Corp (NASDAQ: AVCT) with an Underweight rating.

• Auxilium Pharmaceuticals (NASDAQ: AUXL) was initiated with an Outperform rating at Cowen, which said AUXL's lead candidate, AA4500, is in pivotal testing for Dupuytren's contracture, which could be a $400M+ revenue opportunity.

• BioSante Pharmaceuticals (AMEX: BPA) was initiated with a Positive rating at Susquehanna, as the firm is positive on BPA's growth prospects for the transdermal estrogen market, upside potential from the female dysfunction market, and valuation.

OTHER INITIATIONS:

• Morgan Stanley initiated shares of Lamar Advertising (NASDAQ: LAMR) with an Overweight rating and $77 target.

• SunTrust Robinson Humphrey initiated shares of Texas Roadhouse (NASDAQ: TXRH) with a Neutral rating.

• Morgan Joseph initiated shares of Metalico (AMEX: MEA) with a Hold rating.

• Stifel Nicolaus initiated shares of Tenet Healthcare (NYSE: THC) with a Sell rating and a $5 target.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).